Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Coherus Oncology Inc
SWB:8C5
Coherus Oncology Inc
SWB:8C5
Price:
1.261
EUR
-1.25%
Market Cap:
€140.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
Coherus Oncology Inc
SWB:8C5
|
US |
|
C
|
China Oilfield Services Ltd
OTC:CHOLF
|
CN |
|
I
|
Immunotech Laboratories Inc
OTC:IMMB
|
US |
|
S
|
Southern Cross Media Group Ltd
SWB:6MM
|
AU |
|
S
|
Southern Cross Media Group Ltd
F:6MM
|
AU |
|
Standard BioTools Inc
NASDAQ:LAB
|
US |
|
Valaris Ltd
NYSE:VAL
|
BM |
|
E
|
Eurazeo SE
XMUN:EUQ
|
FR |
|
P
|
Pomvom Ltd
TASE:PMVM
|
IL |
|
L
|
Leon's Furniture Ltd
OTC:LEFUF
|
CA |
|
Trisula International Tbk PT
IDX:TRIS
|
ID |
|
P
|
PPG Industries Inc
XMUN:PPQ
|
US |
|
P
|
Pakistan State Oil Company Ltd
KAR:PSO
|
PK |
Wall St Price Targets
8C5 Price Forecast
Based on 5 analysts
Based on 5 analysts
+403% Upside
from
€1.261
today
Coherus Oncology Inc (8C5)’s 12-month stock price forecast through August 2027 has a consensus target of €6.339, implying 403% upside. The forecast is based on price targets from 5 Wall Street analysts.
8C5 Analyst Rating
No ratings yet
No ratings yet
Coherus Oncology Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 8C5's stock price target?
Price Target
6.339
EUR
6.339
EUR
According to Wall Street analysts, the average 1-year price target for 8C5 is 6.339 EUR with a low forecast of 3.587 EUR and a high forecast of 9.322 EUR.
What is the Revenue forecast for Coherus Oncology Inc?
Projected CAGR
44%
44%
Over the last 12 years, the compound annual growth rate for Revenue has been 25%. The projected CAGR for the next 8 years is 44%.
What is the Gross Profit forecast for Coherus Oncology Inc?
Projected CAGR
47%
47%
The compound annual growth rate for Gross Profit over the next 7 years is 47%.
What is the Net Income forecast for Coherus Oncology Inc?
Projected CAGR
10%
10%
The compound annual growth rate for Net Income over the next 8 years is 10%.
